Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Probiotics are viable microorganisms that are increasingly used for treatment of a variety of diseases. Occasionally, however, probiotics may have adverse clinical effects, including septicemia. Here we examined the role of the intestinal microbiota and the adaptive immune system in preventing translocation of probiotics (e.g.,Escherichiacoli Nissle). We challenged C57BL/6J mice raised under germfree conditions (GF-raised C57BL/6J mice) and Rag1−/−mice raised under germfree conditions (GF-raised Rag1−/−mice) and under specific-pathogen-free conditions (SPF-raised Rag1−/−mice) with probiotic E. coli strain Nissle 1917, strain Nissle 1917 mutants, the commensal strain E. coli mpk, or Bacteroides vulgatus mpk. Additionally, we reconstituted Rag1−/−mice with CD4+T cells.E. coli translocation and dissemination and the mortality of mice were assessed. In GF-raised Rag1−/−mice, but not in SPF-raised Rag1−/−mice or GF-raised C57BL/6J mice, oral challenge with E. coli strain Nissle 1917, but not oral challenge with E. coli mpk, resulted in translocation and dissemination. The mortality rate was significantly higher for E. coli strain Nissle 1917-challenged GF-raised Rag1−/−mice (100%;P< 0.001) than for E. coli strain Nissle 1917-challenged SPF-raised Rag1−/−mice (0%) and GF-raised C57BL/6J mice (0%). Translocation of and mortality due to strain E. coli Nissle 1917 in GF-raised Rag1−/−mice were prevented when mice were reconstituted with T cells prior to strain E. coli Nissle 1917 challenge, but not when mice were reconstituted with T cells after E. coli strain Nissle 1917 challenge. Cocolonization experiments revealed that E. coli mpk could not prevent translocation of strain E. coli Nissle 1917. Moreover, we demonstrated that neither lipopolysaccharide structure nor flagella play a role in E. coli strain Nissle 1917 translocation and dissemination. Our results suggest that if both the microbiota and adaptive immunity are defective, translocation across the intestinal epithelium and dissemination of the probiotic E. coli strain Nissle 1917 may occur and have potentially severe adverse effects. Future work should define the possibly related molecular factors that promote probiotic functions, fitness, and facultative pathogenicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A microbial symbiosis factor prevents intestinal inflammatory disease
Mazmanian, S. K., Round, J. L., & Kasper, D. L. (2008) · Nature · doi:10.1038/nature07008 · Cited by 2,340
Besselink, M. G., van Santvoort, H. C., Buskens, E., Boermeester, M. A., van Goor, H., Timmerman, H. M., Nieuwenhuijs, V. B., Bollen, T. L., van Ramshorst, B., Witteman, B. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60207-x · Cited by 1,367
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 4×
“To assess the impact of the intestinal microbiota on protection of mice with severely compromised adaptive immunity (30) from bacterial translocation, we challenged GF- or SPF-raised Rag1 / mice orally with E. coli strain Nissle 1917, a probiotic E. coli strain used to treat IBD and other intestinal diseases (36), or…”
BackgroundInfluentialLin, H.-C., Hsu, C.-H., Chen, H.-L., Chung, M.-Y., Hsu, J.-F., Lien, R.-I., Tsao, L.-Y., Chen, C.-H., & Su, B.-H. (2008) · Pediatrics · doi:10.1542/peds.2007-3007 · Cited by 506
Lupp, C., Robertson, M. L., Wickham, M. E., Sekirov, I., Champion, O. L., Gaynor, E. C., & Finlay, B. B. (2007) · Cell Host & Microbe · doi:10.1016/j.chom.2007.08.002 · Cited by 501
Pathogenic relevance of Lactobacillus: A retrospective review of over 200 cases
Cannon, J. P., Lee, T. A., Bolanos, J. T., & Danziger, L. H. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1253-y · Cited by 478 · cited 1×
“However, all probiotic bacterial species are not equally beneficial, and each species may have individual mechanisms of action due to specific metabolic activities and cellular structures (10).”
BackgroundWaidmann, M., Bechtold, O., Frick, J.-S., Lehr, H.-A., Schubert, S., Dobrindt, U., Loeffler, J., Bohn, E., & Autenrieth, I. B. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00672-3 · Cited by 234 · cited 2×
“gene PCR analyses of stool samples from mice, as described previously (45).”
MethodSelf-citationEfficacy of Probiotics in Irritable Bowel Syndrome: A Meta-Analysis of Randomized, Controlled Trials
Nikfar, S., Rahimi, R., Rahimi, F., Derakhshani, S., & Abdollahi, M. (2008) · Diseases of the Colon & Rectum · doi:10.1007/s10350-008-9335-z · Cited by 155
Sever Sepsis After Probiotic Treatment With Escherichia coli NISSLE 1917
Guenther, K., Straube, E., Pfister, W., Guenther, A., & Huebler, A. (2010) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e3181c36eb9 · Cited by 63
Cited by
Maltby, R., Leatham-Jensen, M. P., Gibson, T., Cohen, P. S., & Conway, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053957 · Cited by 285
“coli Nissle 1917 was able to translocate through the epithelial layer, leading to dissemination, septicemia, and death of the animals [34].”
Fábrega, M.-J., Rodríguez-Nogales, A., Garrido-Mesa, J., Algieri, F., Badía, J., Giménez, R., Gálvez, J., & Baldomà, L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01274 · Cited by 240
“Remarkably, OMVs as non-replicative bacterial forms further reduce the low risk of adverse events associated with the administration of the probiotic (Bleich et al., 2008; Gronbach et al., 2010; Olier et al., 2012).”
BackgroundHuys, G., Botteldoorn, N., Delvigne, F., De Vuyst, L., Heyndrickx, M., Pot, B., Dubois, J., & Daube, G. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300065 · Cited by 132
“coli Nissle strain 1917 was assessed under different conditions of defective immunity and intestinal microbiota [80].”
BackgroundEscherichia coli Nissle 1917 (Mutaflor): New Insights into an Old Probiotic Bacterium
Jacobi, C. A., & Malfertheiner, P. (2011) · Digestive Diseases · doi:10.1159/000333307 · Cited by 95
The gut microbiota as a mediator of metabolic benefits after bariatric surgery
Anhê, F. F., Varin, T. V., Schertzer, J. D., & Marette, A. (2017) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.02.002 · Cited by 93
Metadata
- Authors
- Gronbach, K., Eberle, U., Müller, M., Ölschläger, T. A., Dobrindt, U., Leithäuser, F., Niess, J. H., Döring, G., Reimann, J., Autenrieth, I. B., & Frick, J.-S.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2010-07
- Volume
- 78
- Issue
- 7
- Pages
- 3036-3046
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2101942841
- Cited by
- 62
- References
- 9
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host. https://app.cochat.ai/papers/10.1128/iai.00218-10
- The paper
- Gronbach, K., Eberle, U., Müller, M., Ölschläger, T. A., Dobrindt, U., Leithäuser, F., Niess, J. H., Döring, G., Reimann, J., Autenrieth, I. B., & Frick, J.-S. (2010). Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host. Infection and Immunity. https://doi.org/10.1128/iai.00218-10
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.